481 related articles for article (PubMed ID: 26389682)
1. Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.
Panza F; Solfrizzi V; Seripa D; Imbimbo BP; Santamato A; Lozupone M; Prete C; Greco A; Pilotto A; Logroscino G
Expert Opin Pharmacother; 2015; 16(17):2581-8. PubMed ID: 26389682
[TBL] [Abstract][Full Text] [Related]
2. An update on the advancements in the treatment of agitation in Alzheimer's disease.
Porsteinsson AP; Antonsdottir IM
Expert Opin Pharmacother; 2017 Apr; 18(6):611-620. PubMed ID: 28300462
[TBL] [Abstract][Full Text] [Related]
3. Advancements in the treatment of agitation in Alzheimer's disease.
Antonsdottir IM; Smith J; Keltz M; Porsteinsson AP
Expert Opin Pharmacother; 2015; 16(11):1649-56. PubMed ID: 26159445
[TBL] [Abstract][Full Text] [Related]
4. A 2023 update on the advancements in the treatment of agitation in Alzheimer's disease.
Lee D; Clark ED; Antonsdottir IM; Porsteinsson AP
Expert Opin Pharmacother; 2023 Apr; 24(6):691-703. PubMed ID: 36958727
[TBL] [Abstract][Full Text] [Related]
5. Risks and benefits of current and novel drugs to treat agitation in Alzheimer's disease.
Herrmann N; Wang HJ; Song BX; Bawa KK; Lanctôt KL
Expert Opin Drug Saf; 2022 Oct; 21(10):1289-1301. PubMed ID: 36252087
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments.
Liu CS; Ruthirakuhan M; Chau SA; Herrmann N; Carvalho AF; Lanctôt KL
Curr Alzheimer Res; 2016; 13(10):1134-44. PubMed ID: 27137221
[TBL] [Abstract][Full Text] [Related]
7. AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.
Garay RP; Grossberg GT
Expert Opin Investig Drugs; 2017 Jan; 26(1):121-132. PubMed ID: 27936965
[TBL] [Abstract][Full Text] [Related]
8. Can antidepressant medication relieve agitation in Alzheimer's disease?
Porsteinsson AP; Smith JS; Keltz MA; Antonsdottir IM
Expert Rev Neurother; 2014 Sep; 14(9):969-71. PubMed ID: 25148535
[TBL] [Abstract][Full Text] [Related]
9. Investigational drugs for treating agitation in persons with dementia.
Garay RP; Citrome L; Grossberg GT; Cavero I; Llorca PM
Expert Opin Investig Drugs; 2016 Aug; 25(8):973-83. PubMed ID: 27232589
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.
Liu CS; Chau SA; Ruthirakuhan M; Lanctôt KL; Herrmann N
CNS Drugs; 2015 Aug; 29(8):615-23. PubMed ID: 26271310
[TBL] [Abstract][Full Text] [Related]
11. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Ballard C; Waite J
Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
[TBL] [Abstract][Full Text] [Related]
13. When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram.
Aga VM
Am J Geriatr Psychiatry; 2019 Oct; 27(10):1099-1107. PubMed ID: 31288974
[TBL] [Abstract][Full Text] [Related]
14. Role of citalopram in the treatment of agitation in Alzheimer's disease.
Porsteinsson AP; Keltz MA; Smith JS
Neurodegener Dis Manag; 2014; 4(5):345-9. PubMed ID: 25405648
[TBL] [Abstract][Full Text] [Related]
15. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
16. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease.
Creese B; Da Silva MV; Johar I; Ballard C
Expert Rev Neurother; 2018 Jun; 18(6):461-467. PubMed ID: 29764230
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole in the treatment of Alzheimer's disease.
De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis.
Kongpakwattana K; Sawangjit R; Tawankanjanachot I; Bell JS; Hilmer SN; Chaiyakunapruk N
Br J Clin Pharmacol; 2018 Jul; 84(7):1445-1456. PubMed ID: 29637593
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
20. Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.
Cummings JL; Lyketsos CG; Peskind ER; Porsteinsson AP; Mintzer JE; Scharre DW; De La Gandara JE; Agronin M; Davis CS; Nguyen U; Shin P; Tariot PN; Siffert J
JAMA; 2015 Sep 22-29; 314(12):1242-54. PubMed ID: 26393847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
